North East and North Cumbria
ICS Formulary
ICS Formulary
1 Gastro-intestinal system
01-02 Motility stimulants
| Domperidone |
|
Formulary
|
Tablets - 10mg Suspension - 5mg/5ml MHRA Drug Safety Alert (May 2014): Domperidone: risk of cardiac side effects |
|
| Metoclopramide |
|
Formulary
|
Tablets - 10mg Oral Solution - 5mg/5ml MHRA Drug Safety Update Alert (Aug 2013): Metoclopramide: risk of neurological adverse effects |
|
|
Links
County Durham and Tees Valley Guidance for Prescribing and Monitoring in Post Bariatric Surgery in Primary Care
Guidelines for the Management of Adults with Asymptomatic Liver Blood Test Abnormalities- MHRA Drug Safety Update (Feb 2017): Hyoscine butylbromide (Buscopan) injection: risk of serious adverse effects in patients with underlying cardiac disease
- NICE CG49: Faecal incontinence
- NICE CG99: Constipation in children and young people
- North of Tyne, Gateshead and North Cumbria - Management of patients, post-bariatric surgery in primary care
- NTAG: Transanal irrigation (TAI) systems (Peristeen Plus®, Aquaflush®, and QuFora®) for neurogenic bowel dysfunction, chronic constipation and chronic faecal incontinence